Company profile: Helomics
1.1 - Company Overview
Company description
- Provider of comprehensive, personalized tumor profiling for oncology, utilizing proprietary tissue-based live-cell and fixed-cell laboratory platforms to deliver next-generation diagnostics aimed at improving patient outcomes.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Helomics
Ovation Fertility
HQ: United States
Website
- Description: Provider of assisted reproductive technology through a network of IVF and genetics labs, offering comprehensive IVF and andrology lab services; frozen donor eggs; surrogacy services matching intended parents with pre-screened gestational carriers; long-term storage of eggs, sperm, and embryos; preconception carrier screening and PGT; and off-site lab direction for IVF labs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ovation Fertility company profile →
Personalis
HQ: United States
Website
- Description: Provider of contract research and genome-scale diagnostics services specializing in genome-guided medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Personalis company profile →
Chronix Biomedical
HQ: United States
Website
- Description: Provider of molecular diagnostics leveraging proprietary technology to measure and categorize circulating nucleic acids in blood, developing blood tests to monitor minimal residual disease in cancer patients and supporting diagnosis and management of chronic diseases and cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chronix Biomedical company profile →
Idenix
HQ: United States
Website
- Description: Provider of biopharmaceutical research and development focused on discovering and developing drugs to treat human viral diseases, with an emphasis on hepatitis C virus (HCV), with operations in the United States and Europe.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Idenix company profile →
Lantern Pharma
HQ: United States
Website
- Description: Provider of AI, machine learning, and genomics-enabled precision oncology therapies, offering RADR, an AI/ML platform to accelerate cancer drug development, and drug candidates including LP-300 (Phase 2 for relapsed advanced primary lung adenocarcinoma in never smokers), LP-184 (anticancer activity in solid tumors with homologous recombination deficiency), LP-284 (preclinical in non-Hodgkin’s lymphoma and DNA repair-deficient cells), Irofulven, and Dimensa to reduce chemotherapeutic toxicity and treat taxane-induced neuropathies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lantern Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Helomics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Helomics
2.2 - Growth funds investing in similar companies to Helomics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Helomics
4.2 - Public trading comparable groups for Helomics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →